David Henshall is the Coordinator of EPICLUSTER. His undergraduate degree was in Pharmacology from the University of Bristol, and he gained his PhD in Neuropharmacology in 1997 from the University of Edinburgh. Post-doctoral training was at the Department of Neurology, University of Pittsburgh, USA. Later, David moved to the Robert S. Dow Neurobiology Laboratories, a private non-profit research institute in Portland, Oregon, USA and then in 2004 moved to the Royal College of Surgeons in Ireland (now RCSI University of Medicine & Health Sciences). Where he is currently Professor of Molecular Physiology & Neuroscience. David has published over 200 papers on the mechanisms and treatment of brain disease with a special focus on drug-resistant epilepsy. He coordinated the European FP7 large-scale collaborative project EpimiRNA (2013 – 2018) and co-organised the international conferences EpiXchange I and II. He is the Chair of the International League Against Epilepsy Neurobiology Commission’s Task Force on Genetics/Epigenetics and a Benchmark Steward for the National Institutes of Neurological Disorders and Stroke. In 2017, he became Director of FutureNeuro, a €13Mio Science Foundation Ireland Research Centre focused on chronic and rare neurological diseases. The Centre is an industry-academia partnership model working to translate findings for patient benefit and includes world-leading investigators in the areas of clinical neurology, genetics, materials science and eHealth.
